Sanofi (SNY) Other Non-Current Liabilities (2016 - 2025)
Sanofi's Other Non-Current Liabilities history spans 17 years, with the latest figure at $7.8 billion for Q4 2025.
- On a quarterly basis, Other Non-Current Liabilities fell 9.81% to $7.8 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $7.8 billion, a 9.81% decrease, with the full-year FY2025 number at $7.8 billion, down 9.81% from a year prior.
- Other Non-Current Liabilities hit $7.8 billion in Q4 2025 for Sanofi, down from $8.1 billion in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for SNY hit a ceiling of $8.9 billion in Q2 2024 and a floor of $1.3 billion in Q4 2022.
- Historically, Other Non-Current Liabilities has averaged $6.7 billion across 5 years, with a median of $7.9 billion in 2025.
- Biggest five-year swings in Other Non-Current Liabilities: dropped 28.44% in 2021 and later soared 550.2% in 2023.
- Tracing SNY's Other Non-Current Liabilities over 5 years: stood at $1.3 billion in 2021, then dropped by 1.64% to $1.3 billion in 2022, then soared by 550.2% to $8.2 billion in 2023, then increased by 5.77% to $8.7 billion in 2024, then fell by 9.81% to $7.8 billion in 2025.
- Business Quant data shows Other Non-Current Liabilities for SNY at $7.8 billion in Q4 2025, $8.1 billion in Q2 2025, and $8.7 billion in Q4 2024.